Purchase Order 12405B23P0302
- Not listed
- Genscript USA Inc., a biotechnology company based in New Jersey, was awarded a $6,463.55 firm fixed-price purchase order contract by the USDA's Northeast Area to generate an IFNAR1 knockout HEK293 cell line. This contract is not set aside for any specific business category. Genscript has a significant blanket purchase agreement (BPA) worth up to $1.5 million with USDA's Animal and Plant Health Inspection Service (APHIS) to provide SARS-CoV-2 surrogate virus neutralization test kits and...
- This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...
- Genscript USA Inc. has been awarded a $249,900 firm fixed price call against the SARS-COV-2 Surrogate Virus Neutralization Test Kits blanket purchase agreement by the United States Department of Agriculture Animal and Plant Health Inspection Service Marketing and Regulatory Programs Business Services. Under the contract, Genscript will provide SARS-COV-2 surrogate virus neutralization test kits to support the Department of Agriculture's efforts to monitor and research diseases affecting animal...
- The federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to GenScript USA Incorporated, a biotechnology company based in Piscataway, New Jersey. The $35,155.40 firm fixed-price purchase order did not have a set-aside designation. The contract supports GenScript's provision of specialized biological materials and services, including gene synthesis, protein production, and antibody...
- This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- Genscript USA Inc. was awarded a $172,800 firm fixed price blanket purchase agreement call contract by the Department of Agriculture Animal and Plant Health Inspection Service Wildlife Services to provide SARS-COV-2 surrogate virus neutralization testing. The testing will support Wildlife Services' research and development efforts through June 2023. No set-aside provisions were applied to this contract awarded under the agency's SARS-COV-2 surrogate virus neutralization test blanket purchase...
- This is a $164,700 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support critical research initiatives, with a period of performance through June 15, 2026. While the contract does not have a set-aside...
- This federal contract award, valued at $88,327.43, was issued by the U.S. Department of Agriculture (USDA) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, which is a firm fixed-price purchase order, is for the provision of DNA fragments with 100% guaranteed sequence to support the USDA's Agricultural Research Service (ARS) Plains Area. This award is set aside for small businesses and was made under a solicitation that had a North American Industry...
- The Department of Agriculture Agricultural Research Service Field Research Implementation and Information Delivery awarded a purchase order valued at $24,796.45 to Genscript USA Inc. The contract calls for Genscript to provide custom anti car I 2 monoclonal antibody in support of USDA research efforts. Specifically, the solicitation requested quotes for the antibody meeting associated technical specifications, price breakdowns, and descriptive literature demonstrating compliance. The place of...
The U.S. Department of Agriculture (USDA) awarded a $6,701.14 firm fixed-price purchase order to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of antibodies against avian herpesvirus antigens, which supports USDA's animal disease monitoring and research efforts. This award is part of a larger $1.5 million blanket purchase agreement (BPA) between Genscript and USDA's Animal and Plant Health Inspection Service (APHIS) to provide SARS-CoV-2 surrogate virus neutralization test kits and associated reagents. The contract does not have a set-aside designation. Through this award and the broader BPA, Genscript leverages its expertise in gene synthesis, protein expression, and antibody production to assist USDA's work in understanding disease transmission and evaluating control strategies for emerging zoonotic threats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $520 | 7/29/24 | |
| Not listed | Not listed | $6.2k | 8/8/23 |